Diabetes, Vol 48, Issue 10 2074-2082, Copyright © 1999 by American Diabetes Association

ARTICLES

Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products

BF Liu, S Miyata, H Kojima, A Uriuhara, H Kusunoki, K Suzuki and M Kasuga
Second Department of Internal Medicine, Kobe University School of Medicine, Japan.

Formation of advanced glycation end products (AGEs) is accelerated in diabetic subjects along with hyperglycemia. Although several lines of evidence indicate that AGEs stimulate macrophages to secrete several cytokines and growth factors, little is known about the effect of AGEs on the primary function of macrophages, such as phagocytosis. On the other hand, impairment of the phagocytic function of monocytes/macrophages is suggested to contribute to the low resistance to infection in diabetic subjects. In the present study, we examined the effect of AGEs on the phagocytic function of macrophages. Using flow cytometric analysis of mouse resident peritoneal macrophages, we showed that AGEs suppress phagocytosis of fluorescent microspheres by cultured macrophages. In addition, experiments using streptozotocin-induced diabetic mice demonstrated a significant decrease in the phagocytic activity of resident peritoneal macrophages 12 weeks after induction of diabetes compared with age-matched control mice. The phagocytic activity of peritoneal macrophages correlated inversely with AGE content in the adjacent peritoneal tissue. Furthermore, reduced phagocytic activity of macrophages was associated with a reduction in intracellular ATP content. Because phagocytosis is an important component of the defense system, suppression of such activity by AGEs may explain, at least in part, the increased susceptibility of diabetic patients to infection.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. W. Martens, M. C. Arikan, J. Lee, F. Ren, D. Greiner, and H. Kornfeld Tuberculosis Susceptibility of Diabetic Mice Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 518 - 524. [Abstract] [Full Text] [PDF]

				S. H. Han, S. C. Lee, S. V. Ahn, J. E. Lee, D. K. Kim, T. H. Lee, S. J. Moon, B. S. Kim, S.-W. Kang, K. H. Choi, et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2653 - 2658. [Abstract] [Full Text] [PDF]

				A Lecleire-Collet, L H Tessier, P Massin, V Forster, G Brasseur, J A Sahel, and S Picaud Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants Br. J. Ophthalmol., December 1, 2005; 89(12): 1631 - 1633. [Abstract] [Full Text] [PDF]

				M. E. Hartman, J. C. O'Connor, J. P. Godbout, K. D. Minor, V. R. Mazzocco, and G. G. Freund Insulin Receptor Substrate-2-dependent Interleukin-4 Signaling in Macrophages Is Impaired in Two Models of Type 2 Diabetes Mellitus J. Biol. Chem., July 2, 2004; 279(27): 28045 - 28050. [Abstract] [Full Text] [PDF]

				S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch Management of Diabetes and Hyperglycemia in Hospitals Diabetes Care, February 1, 2004; 27(2): 553 - 591. [Full Text] [PDF]

				F. Weekers, A.-P. Giulietti, M. Michalaki, W. Coopmans, E. Van Herck, C. Mathieu, and G. Van den Berghe Metabolic, Endocrine, and Immune Effects of Stress Hyperglycemia in a Rabbit Model of Prolonged Critical Illness Endocrinology, December 1, 2003; 144(12): 5329 - 5338. [Abstract] [Full Text] [PDF]

				K. S. Collison, R. S. Parhar, S. S. Saleh, B. F. Meyer, A. A. Kwaasi, M. M. Hammami, A. M. Schmidt, D. M. Stern, and F. A. Al-Mohanna RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs) J. Leukoc. Biol., March 1, 2002; 71(3): 433 - 444. [Abstract] [Full Text] [PDF]